Company Filing History:
2 out of 18 
1 out of 99 
Years Active: 2024-2025
Title: Innovations and Contributions of Inventor Kai-Wen Kan
Introduction
Kai-Wen Kan is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of biotechnology, particularly in cancer treatment and cell therapy. With a total of 2 patents, his work has garnered attention for its innovative approaches to medical challenges.
Latest Patents
Kai-Wen Kan's latest patents include a fusion protein and nucleic acid encoding sequence, which are designed for various therapeutic applications. The fusion protein aims to treat cancer, regulate immune responses, and activate immune cells through a series of efficacy experiments. Another significant patent involves a tumor microenvironment on a biochip, which integrates microfluidic technology with cell culture. This invention is intended for detecting and testing the functionality of cell therapies for cancer or tumors.
Career Highlights
Throughout his career, Kai-Wen Kan has worked with esteemed institutions such as China Medical University Hospital and China Medical University. His research and innovations have contributed to advancements in medical technology and therapeutic strategies.
Collaborations
Some of his notable collaborators include Der-Yang Cho and Shao-Chih Chiu. Their joint efforts have furthered the development of innovative solutions in the field of biotechnology.
Conclusion
Kai-Wen Kan's contributions to the field of biotechnology, particularly in cancer treatment and cell therapy, highlight his role as a significant inventor. His innovative patents and collaborations reflect his commitment to advancing medical science.